ADAM-17: the enzyme that does it all

Area of Science:

• Biochemistry
• Molecular Biology
• Pathophysiology

Background:

• ADAM-17, initially identified as tumor necrosis factor converting enzyme (TACE), is a key regulator of cellular processes.
• Its function involves the cleavage of diverse substrates, including cytokines, growth factors, receptors, and adhesion molecules.
• This enzymatic activity impacts cellular events such as proliferation and migration.

Purpose of the Study:

• To review the multifaceted role of ADAM-17 in various human diseases.
• To highlight ADAM-17 as a potential therapeutic target for numerous pathological conditions.
• To emphasize the need for understanding ADAM-17's regulatory mechanisms and tissue-specific targeting for therapeutic exploitation.

Main Methods:

• This review synthesizes existing research on ADAM-17's function and its involvement in disease.
• Literature analysis focusing on the substrates and cellular context of ADAM-17 activity.
• Exploration of the implications of ADAM-17 dysregulation in disease pathophysiology.

Main Results:

• ADAM-17 plays an indispensable role in regulating fundamental cellular events.
• The enzyme is implicated in a wide spectrum of diseases, including cancer, cardiovascular disease, diabetes, rheumatoid arthritis, kidney fibrosis, and Alzheimer's disease.
• ADAM-17's specific role is highly context-dependent, varying across different cell types and tissues.

Conclusions:

• ADAM-17 is a critical enzyme with broad implications in human health and disease.
• Its involvement in multiple pathologies positions it as a promising target for novel therapeutic interventions.
• Further research into ADAM-17 regulation and targeted inactivation/activation is essential for realizing its full therapeutic potential.